Interview with Pharma Boardroom Healthcare & Life Sciences

Responsibilities for the administration of drugs (including biologicals) and medical devices are assumed by several governmental agencies, including the following key players: The National Medical Product Administration (NMPA), formerly known as the China Food and Drug Administration, which is responsible for issuing marketing authorizations of drugs and medical devices and monitoring product quality. The National Health Commission (NHC), which is responsible for the overall guidance of healthcare reform, administering China’s Essential Drug List (EDL) and managing the drug tendering and procurement policies. The Ministry of Human Resources and Social Security (MOHRSS), the authority that takes the lead in formulating the National Drug Reimbursement List (NRDL). What is the regulatory framework for the authorization, pricing, and reimbursement of drugs, biologicals, and medical devices?reimbursement of drugs, biologicals, and medical

Responsibilities for the administration of drugs (including biologicals) and medical devices are assumed by several governmental agencies, including the following key players: The National Medical Product Administration (NMPA), formerly known as the China Food and Drug Administration, which is responsible for issuing marketing authorizations of drugs and medical devices and monitoring product quality. The National Health Commission (NHC), which is responsible for the overall guidance of healthcare reform, administering China’s Essential Drug List (EDL) and managing the drug tendering and procurement policies. The Ministry of Human Resources and Social Security (MOHRSS), the authority that takes the lead in formulating the National Drug Reimbursement List (NRDL). What is the regulatory framework for the authorization, pricing, and reimbursement of drugs, biologicals, and medical devices?reimbursement of drugs, biologicals, and medical

TOP